Dashboard
Manage Tickers

MGNX MACROGENICS INC

Nasdaq macrogenics.com


$ 1.72 $ 0.06 (3.64 %)    

Monday, 20-Oct-2025 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.48 $ 0.00 (0 %)
DIA $ 466.92 $ 0.00 (0 %)
SPY $ 671.38 $ 0.00 (0 %)
TLT $ 92.01 $ 0.00 (0 %)
GLD $ 386.52 $ 0.00 (0 %)
$ 1.71
$ 1.66
$ 1.69 x 100
$ 1.84 x 902
-- - --
$ 0.99 - $ 5.10
817,895
na
108.08M
$ 1.80
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-20-2025 12-31-2024 10-K
4 11-05-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-07-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-15-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 07-29-2021 06-30-2021 10-Q
18 04-29-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 02-25-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 05-01-2019 03-31-2019 10-Q
27 02-26-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-07-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 05-03-2017 03-31-2017 10-Q
35 02-28-2017 12-31-2016 10-K
36 11-02-2016 09-30-2016 10-Q
37 08-03-2016 06-30-2016 10-Q
38 05-04-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-04-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/21/2025 21:06:06

macrogenics-q2-eps-057-beats-075-estimate-sales-22241m-beat-7700m-estimate
Macrogenics Q2 EPS $(0.57) Beats $(0.75) E...
08/14/2025 20:23:11

macrogenics-appoints-eric-risser-as-president-and-ceo-succeeds-scott-koenig
MacroGenics Appoints Eric Risser As Presid...
08/13/2025 20:03:01

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/10/2025 12:09:16

macrogenics-forged-a-zynyz-royalty-purchase-deal-with-sagard-healthcare-partners-for-70m-upfront-payment-extending-cash-runway-through-first-half-of-2027
MacroGenics Forged A ZYNYZ Royalty Purchas...
06/10/2025 11:11:33

MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering, developing, manufacturing a...

4-analysts-assess-macrogenics-what-you-need-to-know
4 Analysts Assess Macrogenics: What You Ne...
05/20/2025 20:00:49

b-riley-securities-maintains-neutral-on-macrogenics-lowers-price-target-to-3
B. Riley Securities Maintains Neutral on M...
05/20/2025 14:52:57

B. Riley Securities analyst Mayank Mamtani maintains Macrogenics (NASDAQ:MGNX) with a Neutral and lowers the price target fr...

stifel-maintains-hold-on-macrogenics-lowers-price-target-to-5
Stifel Maintains Hold on Macrogenics, Lowe...
05/14/2025 15:45:18

Stifel analyst Stephen Willey maintains Macrogenics (NASDAQ:MGNX) with a Hold and lowers the price target from $6 to $5.

barclays-maintains-overweight-on-macrogenics-lowers-price-target-to-3
Barclays Maintains Overweight on Macrogeni...
05/14/2025 15:01:16

Barclays analyst Peter Lawson maintains Macrogenics (NASDAQ:MGNX) with a Overweight and lowers the price target from $8 to $3.

macrogenics-q1-eps-065-beats-076-estimate-sales-1319m-beat-617m-estimate
Macrogenics Q1 EPS $(0.65) Beats $(0.76) E...
05/13/2025 20:21:26

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.76) b...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

a-look-at-macrogenicss-upcoming-earnings-report
A Look at Macrogenics's Upcoming Earnings ...
05/12/2025 21:03:55

hc-wainwright--co-maintains-neutral-on-macrogenics-lowers-price-target-to-2
HC Wainwright & Co. Maintains Neutral on M...
03/25/2025 11:09:16

HC Wainwright & Co. analyst Robert Burns maintains Macrogenics (NASDAQ:MGNX) with a Neutral and lowers the price target ...

macrogenics-2024-eps-107-down-from-015-yoy
MacroGenics 2024 EPS $(1.07) Down From $(0...
03/20/2025 20:12:31

earnings-scheduled-for-march-20-2025
Earnings Scheduled For March 20, 2025
03/20/2025 08:32:14

peeling-back-the-layers-exploring-macrogenics-through-analyst-insights
Peeling Back The Layers: Exploring Macroge...
11/07/2024 15:00:48

jmp-securities-downgrades-macrogenics-to-market-perform
JMP Securities Downgrades Macrogenics to M...
11/07/2024 11:55:20

JMP Securities analyst Silvan Tuerkcan downgrades Macrogenics (NASDAQ:MGNX) from Market Outperform to Market Perform.

hc-wainwright--co-reiterates-neutral-on-macrogenics-maintains-4-price-target
HC Wainwright & Co. Reiterates Neutral on ...
11/06/2024 12:25:03

HC Wainwright & Co. analyst Robert Burns reiterates Macrogenics (NASDAQ:MGNX) with a Neutral and maintains $4 price target.

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
11/06/2024 12:05:33

macrogenics-q3-eps-090-beats-021-estimate-sales-11071m-beat-7611m-estimate
Macrogenics Q3 EPS $0.90 Beats $0.21 Estim...
11/05/2024 21:14:22

Macrogenics (NASDAQ:MGNX) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.21 by ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION